Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Simmbion
company
About
Simmbion offers experimental solutions to the biologics problem based on engineering bacteria, fungi, or viruses.
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $255.13K
- Industries
- Biotechnology,Product Research
- Operating Status
- Active
Simmbion offers symbionts to produce therapeutic agents while avoiding dangerous infections or immune rejection. They supplant the need for complex manufacturing, repeated injections, long hours of infusions, temperature-sensitive storage, high cost of care, and associated compliance issues in a patient-centric, value-driven, and outcome-driven healthcare model.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$255.13K
Simmbion has raised a total of
$255.13K
in funding over 2 rounds. Their latest funding was raised on
Apr 6, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 6, 2022 | Grant | $255.13K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Simmbion is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
